These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
406 related articles for article (PubMed ID: 33970925)
1. The association between the expression of nuclear Yes-associated protein 1 (YAP1) and p53 protein expression profile in breast cancer patients. Cha YJ; Kim D; Bae SJ; Ahn SG; Jeong J; Cho MK; Paik PS; Yoo TK; Park WC; Yoon CI PLoS One; 2021; 16(5):e0250986. PubMed ID: 33970925 [TBL] [Abstract][Full Text] [Related]
2. High Nuclear Expression of Yes-Associated Protein 1 Correlates With Metastasis in Patients With Breast Cancer. Cha YJ; Bae SJ; Kim D; Ahn SG; Jeong J; Koo JS; Yoo TK; Park WC; Lee A; Yoon CI Front Oncol; 2021; 11():609743. PubMed ID: 33718163 [TBL] [Abstract][Full Text] [Related]
3. Real-world Comparison of P53 Immunohistochemistry and TP53 Mutation Analysis Using Next-generation Sequencing. Lee H; Cho YA; Kim DG; Son JY; Cho EY Anticancer Res; 2024 Sep; 44(9):3983-3994. PubMed ID: 39197898 [TBL] [Abstract][Full Text] [Related]
4. The prognostic value of YAP1 on clinical outcomes in human cancers. Wu Y; Hou Y; Xu P; Deng Y; Liu K; Wang M; Tian T; Dai C; Li N; Hao Q; Song D; Zhou LH; Dai Z Aging (Albany NY); 2019 Oct; 11(19):8681-8700. PubMed ID: 31613226 [TBL] [Abstract][Full Text] [Related]
5. Association of nuclear localization of SHP2 and YAP1 with unfavorable prognosis in non-small cell lung cancer. Chen MJ; Wang YC; Wu DW; Chen CY; Lee H Pathol Res Pract; 2019 Apr; 215(4):801-806. PubMed ID: 30685130 [TBL] [Abstract][Full Text] [Related]
6. Yes-Associated Protein 1 as a Novel Prognostic Biomarker for Gastrointestinal Cancer: A Meta-Analysis. Zhang L; Song X; Li X; Wu C; Jiang J Biomed Res Int; 2018; 2018():4039173. PubMed ID: 30539010 [TBL] [Abstract][Full Text] [Related]
7. High Yes-associated protein 1 with concomitant negative LATS1/2 expression is associated with poor prognosis of advanced gastric cancer. Kim E; Ahn B; Oh H; Lee YJ; Lee JH; Lee Y; Kim CH; Chae YS; Kim JY Pathology; 2019 Apr; 51(3):261-267. PubMed ID: 30819540 [TBL] [Abstract][Full Text] [Related]
8. Low Merlin expression and high Survivin labeling index are indicators for poor prognosis in patients with malignant pleural mesothelioma. Meerang M; Bérard K; Friess M; Bitanihirwe BK; Soltermann A; Vrugt B; Felley-Bosco E; Bueno R; Richards WG; Seifert B; Stahel R; Weder W; Opitz I Mol Oncol; 2016 Oct; 10(8):1255-65. PubMed ID: 27378628 [TBL] [Abstract][Full Text] [Related]
9. The expression of YAP1 and other transcription factors contributes to lineage plasticity in combined small cell lung carcinoma. Jimbo N; Ohbayashi C; Fujii T; Takeda M; Mitsui S; Tanaka Y; Itoh T; Maniwa Y J Pathol Clin Res; 2024 Sep; 10(5):e70001. PubMed ID: 39283755 [TBL] [Abstract][Full Text] [Related]
10. Nuclear expression of Yes-associated protein 1 correlates with poor prognosis in intestinal type gastric cancer. Song M; Cheong JH; Kim H; Noh SH; Kim H Anticancer Res; 2012 Sep; 32(9):3827-34. PubMed ID: 22993325 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of immunohistochemically localized biomarkers in stage II and stage III breast cancer: a multivariate analysis. Bhatavdekar JM; Patel DD; Shah NG; Vora HH; Suthar TP; Chikhlikar PR; Ghosh N; Trivedi TI Ann Surg Oncol; 2000 May; 7(4):305-11. PubMed ID: 10819372 [TBL] [Abstract][Full Text] [Related]
12. Low angiomotin-p130 with concomitant high Yes-associated protein 1 expression is associated with adverse prognosis of advanced gastric cancer. Hong SA; Son MW; Cho J; Jang SH; Lee HJ; Lee JH; Cho HD; Oh MH; Lee MS APMIS; 2017 Nov; 125(11):996-1006. PubMed ID: 28885730 [TBL] [Abstract][Full Text] [Related]
13. YAP1 overexpression is associated with poor prognosis of breast cancer patients and induces breast cancer cell growth by inhibiting PTEN. Guo L; Chen Y; Luo J; Zheng J; Shao G FEBS Open Bio; 2019 Mar; 9(3):437-445. PubMed ID: 30868052 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of YAP1 in EGFR mutant lung adenocarcinoma prior to tyrosine kinase inhibitor therapy is associated with poor survival. Hong SA; Jang SH; Oh MH; Kim SJ; Kang JH; Hong SH Pathol Res Pract; 2018 Mar; 214(3):335-342. PubMed ID: 29487002 [TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of Yes-Associated Protein 1 (YAP1) in Various Cancers: A Meta-Analysis. Sun Z; Xu R; Li X; Ren W; Ou C; Wang Q; Zhang H; Zhang X; Ma J; Wang H; Li G PLoS One; 2015; 10(8):e0135119. PubMed ID: 26263504 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of Yes Associated Protein 1, an Independent Prognostic Marker in Patients With Pancreatic Ductal Adenocarcinoma, Correlated With Liver Metastasis and Poor Prognosis. Salcedo Allende MT; Zeron-Medina J; Hernandez J; Macarulla T; Balsells J; Merino X; Allende H; Tabernero J; Ramon Y Cajal S Pancreas; 2017 Aug; 46(7):913-920. PubMed ID: 28697132 [TBL] [Abstract][Full Text] [Related]
17. Coexisting YAP expression and TP53 missense mutations delineates a molecular scenario unexpectedly associated with better survival outcomes in advanced gastric cancer. Pallocca M; Goeman F; De Nicola F; Melucci E; Sperati F; Terrenato I; Pizzuti L; Casini B; Gallo E; Amoreo CA; Vici P; Di Lauro L; Buglioni S; Diodoro MG; Pescarmona E; Mazzotta M; Barba M; Fanciulli M; De Maria R; Ciliberto G; Maugeri-Saccà M J Transl Med; 2018 Sep; 16(1):247. PubMed ID: 30180862 [TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of nuclear Yes-associated protein 1 in patients with nonsmall cell lung cancer: A systematic review and meta-analysis. Zhu L; Ma G; Liu J; Deng Y; Wu Q; Chen W; Zhou Q Medicine (Baltimore); 2019 Apr; 98(16):e15069. PubMed ID: 31008931 [TBL] [Abstract][Full Text] [Related]
19. Physalin A, 13,14-Seco-16, 24-Cyclo-Steroid, Inhibits Stemness of Breast Cancer Cells by Regulation of Hedgehog Signaling Pathway and Yes-Associated Protein 1 (YAP1). Ko YC; Choi HS; Liu R; Lee DS Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445421 [TBL] [Abstract][Full Text] [Related]
20. YAP1 amplification as a prognostic factor of definitive chemoradiotherapy in nonsurgical esophageal squamous cell carcinoma. Dai H; Shao YW; Tong X; Wu X; Pang J; Feng A; Yang Z Cancer Med; 2020 Mar; 9(5):1628-1637. PubMed ID: 31851786 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]